Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices

Circulation

Volumn 93, Issue 8, 1996, Pages 1515-1519

  James, Karen B ^a   McCarthy, Patrick M ^a   Jaalouk, Safwan ^a   Bravo, Emmanuel L ^a   Betkowski, Adam ^a   Thomas, James D ^a   Nakatani, Satoshi ^a   Fouad Tarazi, Fetnat M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

heart failure; heart assist device; plasma

Indexed keywords

ALDOSTERONE; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; RENIN;

ADULT; ARTICLE; ASSISTED CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; IMPLANTATION; MALE; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0029916897     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.8.1515     Document Type: Article

References (22)

1. Navas JP, Martinez-Maldonado M. Pathophysiology of edema in congestive heart failure. Heart Dis Stroke. 1993;2:325-329.
2. Gaffney TE, Braunwald E. Importance of adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. Am J Med. 1963;34:320-324.
3. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A, for the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine plasma renin activity, and congestive heart failure. Circulation. 1993;87(suppl VI):VI-40-VI-48.
4. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659-1666.
5. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J. Am Coll Cardiol. 1989;13:1534-1539.
6. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Mickas J, Liang C, Kubo SH, Rduin-Toretsky E, Yusuf S, for the SOLVD Investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
7. Frazier OH, Rose EA, Macmanus Q, Burton NA, Lefrak EA, Poirier VL, Dasse KA. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992;53:1080-1090.
8. Tarazi RC, Ibrahim MM, Dustan HP, Ferrario CM. Cardiac factors in hypertension. Circ Res. 1974;34(suppl I):I-213-I-221.
9. Bravo EL, Tarazi RC, Dustan HP. The mechanism of suppressed plasma renin activity during β-adrenergic blockade with propranolol. J Lab Clin Med. 1974;83:119-124.
10. Crofton JT, Share L, Wang BC, Shade RE. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension. Hypertension. 1980;2:424-431.
11. Bravo EL, Tarazi RC, Dustan HP, Lewis JW. Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension. Circ Res. 1975;36(suppl I):I-241-I-247.
12. Stoddard MF, Liddell NE, Vogel RL, Longaker RA, Dawkins PR. Comparison of cardiac dimensions by transesophageal and transthoracic echocardiography. Am Heart J. 1992;124:675-678.
13. Drexler M, Erbel R, Müller U, Wittlich N, Mohr-Kahaly S, Meyer J. Measurement of intracardiac dimensions and structures in normal young adult subjects by transesophageal echocardiography. Am J. Cardiol. 1990;65:1491-1496.
14. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg. 1995;59:609-613.
15. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E. The effect of the left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 1995; 92(suppl II):II-191-II-195.
16. Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure: relationship of cardiac index to kidney function. Drugs. 1990;39:(suppl 4):10-21.
17. McCarthy PM, Savage RM, Fraser CD, Vargo R, James KB, Goormastic M, Hobbs RE. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg. 1995;109:409-418.
18. Silke B. Central hemodynamic effects of diuretic therapy in chronic heart failure. Cardiovasc Drugs Ther. 1993;7(suppl 1):45-53.
19. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987;57:17-22.
20. Uretsky BF, Verbalis JG, Murali S, Betschart AR, Kolesar JA, Reddy PS. Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. J Clin Endocrinol Metab. 1990; 71:146-151.
21. Fontana F, Bernardi P, Spagnolo N, Capelli M. Plasma atrial natriuretic factor in low output heart failure syndromes. Klin Wochenschift. 1990;68:313-319.
22. Rodeheffer RJ, Naruse M, Atkinson JB, Naruse K, Burnett JC, Merrill WH, Frist WH, Demura H, Inagami T. Molecular forms of atrial natriuretic factor in normal and failing human myocardium. Circulation. 1993;88:364-371.